Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries

被引:136
|
作者
Dehghan, Mahshid [1 ]
Mente, Andrew [1 ,2 ]
Teo, Koon K. [1 ]
Gao, Peggy [1 ]
Sleight, Peter [3 ]
Dagenais, Gilles [4 ]
Avezum, Alvaro [5 ]
Probstfield, Jeffrey L. [6 ]
Dans, Tony [7 ,8 ]
Yusuf, Salim [1 ]
机构
[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England
[4] Univ Laval, Heart & Lung Inst, Quebec City, PQ G1K 7P4, Canada
[5] Dante Pazzanese Inst Cardiol, Div Res, Sao Paulo, Brazil
[6] Univ Washington, Sch Med, Seattle, WA USA
[7] Philippine Gen Hosp, Sect Adult Med, Manila, Philippines
[8] Philippine Gen Hosp, Med Res Unit, Manila, Philippines
关键词
cardiovascular diseases; diet; epidemiology; nutritional status; secondary prevention; MEDITERRANEAN DIET; MYOCARDIAL-INFARCTION; HEART-DISEASE; LIFE-STYLE; TELMISARTAN; MORTALITY; PATTERNS; QUALITY; STROKE; WOMEN;
D O I
10.1161/CIRCULATIONAHA.112.103234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Diet quality is strongly related to cardiovascular disease (CVD) incidence, but little is known about its impact on CVD events in older people at high risk of CVD and receiving effective drugs for secondary prevention. This study assessed the association between diet quality and CVD events in a large population of subjects from 40 countries with CVD or diabetes mellitus with end-organ damage receiving proven medications. Methods and Results-Overall, 31 546 women and men 66.5 +/- 6.2 years of age enrolled in 2 randomized trials, the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET) and the Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects With Cardiovascular Disease (TRANSCEND), were studied. We used 2 dietary indexes: the modified Alternative Healthy Eating Index and the Diet Risk Score. The association between diet quality and the primary composite outcome of CV death, myocardial infarction, stroke, or congestive heart failure was assessed with Cox proportional hazard regression with adjustment for age, sex, trial enrollment allocation, region, and other known confounders. During the 56-month follow-up, there were 5190 events. Patients in the healthier quintiles of modified Alternative Healthy Eating Index scores had a significantly lower risk of CVD (hazard ratio, 0.78; 95% confidence interval, 0.71-0.87, top versus lowest quintile of modified Alternative Healthy Eating Index). The reductions in risk for CV death, myocardial infarction, and stroke were 35%, 14%, and 19%, respectively. The protective association was consistent regardless of whether patients were receiving proven drugs. Conclusions-A higher-quality diet was associated with a lower risk of recurrent CVD events among people >= 55 years of age with CVD or diabetes mellitus. Highlighting the importance of healthy eating by health professionals would substantially reduce CVD recurrence and save lives globally. Clinical Trial Registration-URL:http://www.clinicaltrials.gov. Unique identifier: NCT00153101. (Circulation. 2012;126:2705-2712.)
引用
收藏
页码:2705 / +
页数:24
相关论文
共 39 条
  • [21] DOSE-RESPONSE ASSOCIATION BETWEEN PULSE PRESSURE AND RISK OF CARDIOVASCULAR MORTALITY AMONG INCIDENT PERITONEAL DIALYSIS PATIENTS: FINDINGS FROM A PROSPECTIVE COHORT STUDY
    Wang, Zheng
    Yu, Dahai
    Cai, Yamei
    Zhang, Xiaoxue
    Zhao, Zhanzheng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [22] The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women
    Vissers, Linda E. T.
    Waller, Michael A.
    van der Schouw, Yvonne T.
    Hebert, James R.
    Shivappa, Nitin
    Schoenaker, Danielle A. J. M.
    Mishra, Gita D.
    ATHEROSCLEROSIS, 2016, 253 : 164 - 170
  • [23] Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
    de Vries, Tamar Irene
    Westerink, Jan
    Bots, Michiel L.
    Asselbergs, Folkert W.
    Smulders, Yvo M.
    Visseren, Frank L. J.
    BMJ OPEN, 2021, 11 (03):
  • [24] TREATMENT INTENSITY OF LIPID LOWERING THERAPY IN HIGH- AND VERY HIGH-RISK PATIENTS FOR THE PREVENTION OF CARDIOVASCULAR EVENTS - BASELINE CHARACTERISTICS FROM THE IRISH COHORT OF THE MULTINATIONAL, OBSERVATIONAL SANTORINI STUDY
    Rai, H.
    Coughlan, J. J.
    Fitzgerald, S.
    Sheahan, R.
    Murphy, R.
    McFadden, E.
    Nolan, D.
    Byrne, R. A.
    HEART, 2023, 109 (SUPPL_6) : A18 - A19
  • [25] Letter by Enas and Varkey Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study"
    Enas, Enas A.
    Varkey, Basil
    CIRCULATION, 2022, 145 (05) : E146 - E146
  • [26] Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database
    Weir, Sharada
    Juhasz, Attila
    Puelles, Jorge
    Tierney, Travis S.
    BMJ OPEN, 2017, 7 (07):
  • [27] Response by Patel and Khera to Letter Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study"
    Patel, Aniruddh P.
    Khera, Amit V.
    CIRCULATION, 2022, 145 (05) : E147 - E148
  • [28] Risk model for clinically relevant neutropenic event among patients with non hematological tumors receiving chemotherapy regimens not classified as high-risk for febrile neutropenia: results from a multicenter prospective cohort study (NEURISK)
    Munoz-Langa, J.
    Borrega, P.
    Garcia-Bueno, J. M.
    Purificacion Martinez del Prado, P.
    Campos, J. M.
    Quindos, M.
    Lopez Castro, R.
    Valenti Moreno, V.
    Jimenez Orozco, E.
    Lazaro, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 395, pg 795, 2020)
    Yusuf, S.
    Joseph, P.
    Rangarajan, S.
    LANCET, 2020, 395 (10226): : 784 - 784
  • [30] Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
    Walli-Attaei, Marjan
    Joseph, Philip
    Rosengren, Annika
    Chow, Clara K.
    Rangarajan, Sumathy
    Lear, Scott A.
    AlHabib, Khalid F.
    Davletov, Kairat
    Dans, Antonio
    Lanas, Fernando
    Yeates, Karen
    Poirier, Paul
    Teo, Koon K.
    Bahonar, Ahmad
    Camilo, Felix
    Chifamba, Jephat
    Diaz, Rafael
    Didkowska, Joanna A.
    Irazola, Vilma
    Ismail, Rosnah
    Kaur, Manmeet
    Khatib, Rasha
    Liu, Xiaoyun
    Manczuk, Marta
    Miranda, J. Jaime
    Oguz, Aytekin
    Perez-Mayorga, Maritza
    Szuba, Andrzej
    Tsolekile, Lungiswa P.
    Varma, Ravi Prasad
    Yusufali, Afzalhussein
    Yusuf, Rita
    Wei, Li
    Anand, Sonia S.
    Yusuf, Salim
    LANCET, 2020, 396 (10244): : 97 - 109